Evidence map›Paper›PMID 37050607›Full record

ArticleSensors (Basel, Switzerland)2023

An IoMT-Based Melanoma Lesion Segmentation Using Conditional Generative Adversarial Networks.

Zeeshan Ali, Sheneela Naz, Hira Zaffar, Jaeun Choi, Yongsung Kim

Abstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zeeshan AliR & D Setups, National University of Computer and Emerging Sciences, Islamabad 44000, Pakistan.
Sheneela NazDepartment of Computer Science, COMSATS University Islamabad, Islamabad 45550, Pakistan.
Hira ZaffarDepartment of Computer Science, Air University, Aerospace and Aviation Kamra Campus, Islamabad 44000, Pakistan.ORCID 0000-0002-9103-5238
Jaeun ChoiCollege of Business, Kwangwoon University, Seoul 01897, Republic of Korea.ORCID 0000-0003-0097-2590
Yongsung KimDepartment of Technology Education, Chungnam National University, Daejeon 34134, Republic of Korea.

Funding

Chungnam National University 2022-0557-01
6 · The paper itself

Abstract

Currently, Internet of medical things-based technologies provide a foundation for remote data collection and medical assistance for various diseases. Along with developments in computer vision, the application of Artificial Intelligence and Deep Learning in IOMT devices aids in the design of effective CAD systems for various diseases such as melanoma cancer even in the absence of experts. However, accurate segmentation of melanoma skin lesions from images by CAD systems is necessary to carry out an effective diagnosis. Nevertheless, the visual similarity between normal and melanoma lesions is very high, which leads to less accuracy of various traditional, parametric, and deep learning-based methods. Hence, as a solution to the challenge of accurate segmentation, we propose an advanced generative deep learning model called the Conditional Generative Adversarial Network (cGAN) for lesion segmentation. In the suggested technique, the generation of segmented images is conditional on dermoscopic images of skin lesions to generate accurate segmentation. We assessed the proposed model using three distinct datasets including DermQuest, DermIS, and ISCI2016, and attained optimal segmentation results of 99%, 97%, and 95% performance accuracy, respectively.

Indexed as

MelanomaSkin DiseasesSkin NeoplasmsArtificial IntelligenceHumansImage Processing, Computer-AssistedNeural Networks, Computercomputer-aided designgenerative adversarial networksInternet of Medical Things (IoMT)medical assistancemelanoma lesionskin cancersurvival rate

Identifiers

PMID37050607
PMCPMC10098854

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.